FRST
Primis Financial Corp.
FRST's fundamentals are strong and it looks cheap: trading at 6.6x earnings, about half its usual 13x. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
FRST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FRST's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRST.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
FRST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.6x | $14.64 | — |
| Cheap | 8.9x | $19.82 | +35% |
| Forward | 9.1x | $14.64 | — |
| Fair | 13x | $28.04 | +92% |
| Expensive | 53x | $117 | +697% |
Historical ranges are pointers, not guarantees.
FRST's PE is in its cheap range at 6.6x. On analysts' estimates for next year's earnings, today's price would be 9.1x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
FRST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
FRST has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
FRST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | -28% |
| Q3 2026 | $2.22 | +534% |
| Q2 2026 | $2.15 | +1692% |
| Q1 2026 | $1.87 | +1069% |
| Q4 2025 | $2.49 | +$3.15 |
| Q3 2025 | $0.35 | +$0.46 |
| Q2 2025 | $0.12 | +$0.52 |
| Q1 2025 | $0.16 | +$0.78 |
| Q4 2024 | -$0.66 | -$0.28 |
FRST has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
FRST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.2M | +20% |
| Q2 2026 | $55.8M | +29% |
| Q1 2026 | $45.6M | -22% |
| Q4 2025 | $80.9M | +109% |
| Q3 2025 | $41M | +9.9% |
| Q2 2025 | $43.2M | +21% |
| Q1 2025 | $58.7M | +65% |
| Q4 2024 | $38.8M | +20% |
FRST's revenue is growing: $49M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +0.9 points |
| Q2 2026 | 22% | +15 points |
| Q1 2026 | 23% | -19 points |
| Q4 2025 | 45% | +128 points |
| Q3 2025 | 21% | +24 points |
| Q2 2025 | 6.9% | -1 points |
| Q1 2025 | 42% | +38 points |
| Q4 2024 | -83% | -31 points |
FRST has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
FRST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.8M | +$90.2M |
| Q2 2026 | -$6M | +$35M |
| Q1 2026 | -$54.6M | -259% |
| Q3 2025 | -$11.4M | -355% |
| Q2 2025 | -$41M | -181% |
| Q1 2025 | $34.4M | +$35.4M |
| Q4 2024 | -$35.7M | -152% |
| Q3 2024 | $4.5M | +$5.4M |
FRST has the stronger cash trend. Its trailing FCF is down 42% versus its history, compared with IREN at down 479%.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
FRST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | +0.6% | +155K shares |
| 3 years | +0.6% | +157K shares |
| 5 years | +0.7% | +165K shares |
| Available history | +1.9% | +474K shares |
FRST has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
FRST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -17.4x | Net Cash |
| Q1 2025 | -9.4x | Net Cash |
| Q3 2023 | -7.1x | Net Cash |
FRST has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FRST.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
FRST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 6.2 | Oversold |
FRST's weekly RSI is 44 (neutral) and its Stochastic is 6 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
FRST PE vs Financial Services Sector
| Metric | FRST | Sector median | Relative |
|---|---|---|---|
| PE | 6.6x | 13x | 49% below |
| PE % | 3 | 63 | 60 pts below |
FRST is trading at 6.6x earnings, a 49% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
FRST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 3.4% below |
| 20 week MA | $15.7 | 6.7% below |
| 50 week MA | $14.6 | 0.3% above |
| 100 week MA | $12.5 | 17% above |
| 200 week MA | $11.6 | 27% above |
FRST has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
FRST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.4 | $12.1 | -26% |
| 2021 | $12.1 | $15.0 | +24% |
| 2022 | $15.0 | $11.8 | -21% |
| 2023 | $11.8 | $12.7 | +7.7% |
| 2024 | $12.7 | $11.7 | -7.9% |
| 2025 | $11.7 | $13.0 | +12% |
| 2026 YTD | $13.0 | $14.6 | +12% |
FRST has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.